RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 50 filers reported holding RAIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,584 | -77.3% | 18,084 | -68.4% | 0.00% | – |
| Q2 2023 | $68,682 | -67.7% | 57,235 | +135.3% | 0.00% | – |
| Q1 2023 | $212,556 | +116.2% | 24,320 | +97.9% | 0.00% | – |
| Q4 2022 | $98,296 | +85.5% | 12,287 | +11.8% | 0.00% | – |
| Q3 2022 | $53,000 | -49.5% | 10,987 | -41.2% | 0.00% | – |
| Q2 2022 | $105,000 | +138.6% | 18,670 | +114.2% | 0.00% | – |
| Q1 2022 | $44,000 | -30.2% | 8,717 | +77.9% | 0.00% | – |
| Q4 2021 | $63,000 | +200.0% | 4,901 | +235.2% | 0.00% | – |
| Q3 2021 | $21,000 | +320.0% | 1,462 | +272.0% | 0.00% | – |
| Q2 2021 | $5,000 | – | 393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,637,308 | $25,444,000 | 3.14% |
| Cormorant Asset Management, LP | 2,626,660 | $39,734,000 | 1.35% |
| BVF INC/IL | 1,945,949 | $30,240,000 | 1.13% |
| Logos Global Management LP | 780,331 | $12,126,000 | 1.02% |
| ACUTA CAPITAL PARTNERS, LLC | 162,245 | $2,521,000 | 1.01% |
| LUMINUS MANAGEMENT LLC | 425,000 | $6,605,000 | 0.96% |
| Boxer Capital, LLC | 1,175,000 | $18,260,000 | 0.64% |
| Perceptive Advisors | 5,074,038 | $78,850,000 | 0.51% |
| Lumina Fund Management LLC | 6,000 | $93,000 | 0.04% |
| Monashee Investment Management LLC | 20,000 | $311,000 | 0.04% |